Skip to content
FrontierPicks

Covered

AKAM · Akamai Technologies, Inc.

Conviction · Low Business pivot Catalyst · AI datacenter infrastructureCybersecurity

Updated ·

Against its published line

Above its line on the last close.

How to read this

The red mark is the published kill line — the price that would prove the thesis wrong. The dot is where the name closed on 14 October 2026; a dot left of the mark has closed through its line.

Distance is drawn on a square-root scale, so close calls get the room. Past 8% a row reads well clear, with a hollow dot to show the figure is off the drawn scale. Rows run tightest first.

How a pick is graded

Kill line

A daily close below $85, under the 14 October 2026 close of $91.71 and extending the decline that began after the 25 September 2026 announcement-day high. Disclosed deployment delays or withdrawal of the 2027 growth-acceleration outlook would also end the case.

Not a pickResearch coverage at low conviction. A medium-or-higher call would open a pick on the scoreboard.

Catalyst (1 day ago)

How picks are graded →

The thesis

Akamai Technologies' $11.6 billion Anthropic contract gives its pivot from content delivery to AI infrastructure a large backlog, but about $5.5 billion of planned spending comes before any contract revenue. The third-quarter report on 5 November 2026 settles whether margins, the fourth-quarter spending plan and the 2027 growth outlook hold together. The shares closed at $99.59 on 27 October 2026, 38.2% below the 52-week high of $161.14 and 12.4% lower over three months (adjusted daily closes).

The shares have recovered since the 14 October 2026 close of $91.71 that the previous note recorded. Analyst opinion has split during that recovery. Raymond James upgraded the shares to Strong Buy on 20 October 2026 and kept its $170 target. Piper Sandler lowered its target to $120 on 21 October 2026 and kept an Overweight rating. UBS cut its target to $100 from $148 on 22 October 2026 and kept a Neutral rating.

The narrative is maturing and turning more sceptical: the contract has been public since 25 September 2026, and the target changes since then reprice the cost side rather than the backlog. Akamai announced an AI inference service and an agent execution environment on 27 October 2026 (company news). The earnings date and the share price relative to the $111.33 warrant exercise price remain the two facts that decide the next move.

Bullish and bearish views on Akamai Technologies, Inc.

The bull case on Akamai Technologies, Inc. (AKAM), in brief: Largest contract in company history. The bear case: Spending comes before revenue.

Bull case

  • Largest contract in company history. The seven-year Anthropic agreement is worth $11.6 billion and is expandable by about $9 billion (Benzinga and Boston Globe, 25 September 2026 and 27 September 2026). Akamai expects $150 million to $300 million of contract revenue in the second half of 2027.
  • Cloud growth is measurable. Cloud Infrastructure Services revenue rose 39% to $99 million in the second quarter of 2026. Security revenue rose 10% to $604 million on total revenue of $1.099 billion (Q2 2026 earnings release, 6 August 2026).
  • Some analysts are moving up. Raymond James upgraded Akamai to Strong Buy on 20 October 2026 and maintained a $170 target. Piper Sandler's $120 target and Raymond James's $170 target both sit above the $99.59 close (company news and analyst alerts, 20 October 2026 and 21 October 2026).
  • New product launch. Akamai launched an AI inference service and an agent execution environment on 27 October 2026 (company news). It extends the cloud offering beyond the Anthropic contract.

Bear case

  • Spending comes before revenue. Planned capital expenditure is about $5.5 billion: roughly $1.7 billion in the fourth quarter of 2026, $3.1 billion in 2027 and $700 million in 2028. No contract revenue is expected in 2026 (company announcement as reported by Techi and MarketBeat, 25 September 2026).
  • Targets are being cut. UBS lowered its target to $100 from $148 on 22 October 2026, which is about the level of the $99.59 close, and kept a Neutral rating. Piper Sandler lowered its target to $120 on 21 October 2026; the firm's target was listed at $158 in late September.
  • Dilution is built in. Anthropic holds a seven-year warrant on up to 7.7 million shares, about 5% of shares outstanding, at $111.33 (Techi and Benzinga, 25 September 2026). The $99.59 close is below that exercise price.
  • Buybacks are paused. Management said on 6 August 2026 that repurchases were paused to redirect capital to cloud growth. In the second quarter Akamai spent $410 million on 3 million shares at an average $134.54, well above the current price.

Price setup

The shares closed at $99.59 on 27 October 2026. The 14-day relative strength index (RSI) was 44.2, a neutral reading. The 52-week high is $161.14. The announcement-day high of 25 September 2026 started the decline.

Three closes frame the recent range: $106.93 on 2 October 2026, $91.71 on 14 October 2026 and $99.59 on 27 October 2026. The previous note set a weekly close below $100 as the level that would show the market rejecting the contract. The shares sit just under it. The $111.33 warrant exercise price is the next reference above.

Crowding evidence points to event risk. The earnings report is nine days away, analyst targets span $100 to $170 after the October changes, and $2.6 billion of 0% convertible notes issued on 18 May 2026 can move the shares through hedging. No Form 4 insider sales or new share issuance were reported in company news this month.

Catalysts, next 30 days

  • Q4 2026: the first roughly $1.7 billion of capital expenditure for the Anthropic build begins. Power and data-center availability are tested before any contract revenue.
  • Following days: analyst target revisions after the report. UBS, Piper Sandler and Raymond James have all published new targets within the last two weeks.

Elapsed catalysts

  • 5 November 2026, after the close (4:30 p.m. ET): third-quarter 2026 results and investor call, confirmed by the company. It shows cloud revenue growth against the 39% second-quarter rate, margins and the fourth-quarter spending plan. (passed 1d ago)

What would change the view

The case breaks if Akamai discloses deployment delays on the Anthropic build, withdraws the 2027 growth-acceleration outlook, or reports capital expenditure or operating margin worse than the 25 September 2026 plan. Any of these would show the spending running ahead of the revenue. A daily close below $85, under the 14 October 2026 close of $91.71, would also end the case.

A stronger reading would come from the third-quarter report showing cloud revenue growth at or above the second-quarter rate of 39% while the spending plan is unchanged, and from the shares closing above the $111.33 warrant exercise price. A close above that price would remove the warrant overhang from the reference points that have capped the shares since 25 September 2026.

What it trades with

Akamai trades with two groups: security and content-delivery software, where security revenue was $604 million in the second quarter, and AI-infrastructure names exposed to data-center power and capacity. Anthropic-related news moves the shares independently of the security business. Correlation figures are not available for this note.

Notes

  • News aggregators sometimes misfile Alkami Technology (ALKT) headlines under Akamai (AKAM).
  • Anthropic holds a seven-year warrant on up to 7.7 million shares (about 5%) at $111.33; about 2% vests with the $11.6 billion commitment, the rest only with up to $9 billion of added spending.
  • hedging can move the shares without company news.
  • The company pays no dividend, and share repurchases were paused as of the 6 August 2026 earnings call.

Related · shared themes